FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1565494103> ?p ?o ?g. }

• W1565494103 endingPage "9868" @default.
• W1565494103 startingPage "9863" @default.
• W1565494103 abstract "The VLA integrin subfamily includes receptors for extracellular matrix proteins as well as receptors involved in cell-cell adhesive interactions. We have previously described the up-regulation of VLA integrin-mediated cell attachment to different ligands by the anti-beta 1 TS2/16 monoclonal antibody (mAb) (Arroyo, A. G., Sanchez-Mateos, P., Campanero, M. R., Martin-Padura, I., Dejana, E., and Sanchez-Madrid, F. (1992) J. Cell Biol. 117, 659-670). In this report, we have investigated the mechanism involved in this regulatory effect. The anti-beta 1-mediated regulatory effect on cell adhesion did not require de novo protein synthesis, since it was not affected by pretreatment with either cycloheximide or actinomycin D. To quantitate the effect of the regulatory anti-beta 1 TS2/16 mAb on the affinity of VLA-5 for its ligand, an RGD-containing fragment of fibronectin (FN80), we performed binding studies of radiolabeled soluble FN80 to U-937 cells. The affinity of VLA-5 for FN80 was enhanced about 4-fold in the presence of TS2/16 mAb (Kd = 0.98 +/- 0.07 microM) compared to the functionally irrelevant anti-beta 1 Alex 1/4 mAb (Kd = 4.23 +/- 0.92 microM), whereas no alteration in the number of binding sites was observed. Indeed, the anti-beta 1 TS2/16 mAb is inducing this high affinity state on VLA heterodimers by a direct change on the conformation of these receptors as demonstrated by affinity chromatography analysis using extracellular matrix proteins covalently bound to Sepharose. The yield of VLA-5 fibronectin receptor bound to FN80-Sepharose columns was strongly increased upon treatment of U-937 cell lysates with mAb TS2/16. Moreover, higher concentrations of EDTA were required for eluting the VLA-5 integrin from this matrix. This up-regulatory effect was also observed with F(ab')2 and Fab fragments of the anti-beta 1 TS2/16 mAb, and was also exerted on the purified VLA-5 receptor. Similarly, the yield of VLA-2 retained on a collagen I-Sepharose column was dramatically increased by pretreatment of A375 melanoma cell lysates with the mAb TS2/16. Altogether, these results indicate that the interaction of VLA beta 1 heterodimers with their ligands can be regulated by switching between differently active conformations inherent to the alpha beta 1 receptors." @default.
• W1565494103 created "2016-06-24" @default.
• W1565494103 creator A5001113166 @default.
• W1565494103 creator A5006841984 @default.
• W1565494103 creator A5084762392 @default.
• W1565494103 date "1993-05-01" @default.
• W1565494103 modified "2023-10-18" @default.
• W1565494103 title "A high affinity conformational state on VLA integrin heterodimers induced by an anti-beta 1 chain monoclonal antibody" @default.
• W1565494103 cites W1486175763 @default.
• W1565494103 cites W1507411141 @default.
• W1565494103 cites W1512678034 @default.
• W1565494103 cites W1520666812 @default.
• W1565494103 cites W1552764442 @default.
• W1565494103 cites W1557509594 @default.
• W1565494103 cites W1563119717 @default.
• W1565494103 cites W1604526865 @default.
• W1565494103 cites W1622931835 @default.
• W1565494103 cites W1656991593 @default.
• W1565494103 cites W1973834594 @default.
• W1565494103 cites W1974242613 @default.
• W1565494103 cites W1974342547 @default.
• W1565494103 cites W1990387345 @default.
• W1565494103 cites W1991216662 @default.
• W1565494103 cites W1999922759 @default.
• W1565494103 cites W2003794283 @default.
• W1565494103 cites W2012691080 @default.
• W1565494103 cites W2013381560 @default.
• W1565494103 cites W2018020399 @default.
• W1565494103 cites W2020455973 @default.
• W1565494103 cites W2023770662 @default.
• W1565494103 cites W2025107609 @default.
• W1565494103 cites W2026624464 @default.
• W1565494103 cites W2029231027 @default.
• W1565494103 cites W2031318096 @default.
• W1565494103 cites W2053014663 @default.
• W1565494103 cites W2060623940 @default.
• W1565494103 cites W2065155390 @default.
• W1565494103 cites W2075965099 @default.
• W1565494103 cites W2077702220 @default.
• W1565494103 cites W2089562291 @default.
• W1565494103 cites W2111604219 @default.
• W1565494103 cites W2133148589 @default.
• W1565494103 cites W2135121318 @default.
• W1565494103 cites W2156411608 @default.
• W1565494103 doi "https://doi.org/10.1016/s0021-9258(18)98425-5" @default.
• W1565494103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8486666" @default.
• W1565494103 hasPublicationYear "1993" @default.
• W1565494103 type Work @default.
• W1565494103 sameAs 1565494103 @default.
• W1565494103 citedByCount "104" @default.
• W1565494103 countsByYear W15654941032013 @default.
• W1565494103 countsByYear W15654941032017 @default.
• W1565494103 countsByYear W15654941032019 @default.
• W1565494103 crossrefType "journal-article" @default.
• W1565494103 hasAuthorship W1565494103A5001113166 @default.
• W1565494103 hasAuthorship W1565494103A5006841984 @default.
• W1565494103 hasAuthorship W1565494103A5084762392 @default.
• W1565494103 hasBestOaLocation W15654941031 @default.
• W1565494103 hasConcept C104317684 @default.
• W1565494103 hasConcept C121332964 @default.
• W1565494103 hasConcept C12554922 @default.
• W1565494103 hasConcept C1276947 @default.
• W1565494103 hasConcept C1491633281 @default.
• W1565494103 hasConcept C153911025 @default.
• W1565494103 hasConcept C159654299 @default.
• W1565494103 hasConcept C185592680 @default.
• W1565494103 hasConcept C195687474 @default.
• W1565494103 hasConcept C199185054 @default.
• W1565494103 hasConcept C199360897 @default.
• W1565494103 hasConcept C203014093 @default.
• W1565494103 hasConcept C2776174256 @default.
• W1565494103 hasConcept C36394416 @default.
• W1565494103 hasConcept C41008148 @default.
• W1565494103 hasConcept C542903549 @default.
• W1565494103 hasConcept C55493867 @default.
• W1565494103 hasConcept C71240020 @default.
• W1565494103 hasConcept C84613547 @default.
• W1565494103 hasConcept C86803240 @default.
• W1565494103 hasConceptScore W1565494103C104317684 @default.
• W1565494103 hasConceptScore W1565494103C121332964 @default.
• W1565494103 hasConceptScore W1565494103C12554922 @default.
• W1565494103 hasConceptScore W1565494103C1276947 @default.
• W1565494103 hasConceptScore W1565494103C1491633281 @default.
• W1565494103 hasConceptScore W1565494103C153911025 @default.
• W1565494103 hasConceptScore W1565494103C159654299 @default.
• W1565494103 hasConceptScore W1565494103C185592680 @default.
• W1565494103 hasConceptScore W1565494103C195687474 @default.
• W1565494103 hasConceptScore W1565494103C199185054 @default.
• W1565494103 hasConceptScore W1565494103C199360897 @default.
• W1565494103 hasConceptScore W1565494103C203014093 @default.
• W1565494103 hasConceptScore W1565494103C2776174256 @default.
• W1565494103 hasConceptScore W1565494103C36394416 @default.
• W1565494103 hasConceptScore W1565494103C41008148 @default.
• W1565494103 hasConceptScore W1565494103C542903549 @default.
• W1565494103 hasConceptScore W1565494103C55493867 @default.
• W1565494103 hasConceptScore W1565494103C71240020 @default.
• W1565494103 hasConceptScore W1565494103C84613547 @default.
• W1565494103 hasConceptScore W1565494103C86803240 @default.

• next